<DOC>
	<DOCNO>NCT03017170</DOCNO>
	<brief_summary>A randomized , double-blind , placebo control study evaluate efficacy dry cranberry 500 mg daily woman overactive bladder 6-months .</brief_summary>
	<brief_title>Evaluation Effect Dried Cranberry Powder Women With Dry OAB</brief_title>
	<detailed_description>This 6 month , randomize , prospective , single-center trial conduct outpatient set tertiary care facility . This double-blind , randomize , placebo-controlled parallel study dry cranberry OAB symptom woman . Eligible subject female outpatient age ≥18 year diagnose OAB . All patient provide write informed consent enter study . The study protocol amendment approve appropriate Institutional Review Board . Patients recruit study office Dr. Bilal Chughtai , within Weill Cornell Medical College , include referral WCMC-affiliated primary care physicians involve study , well recruit advertisement ( Craigslist , newspaper , poster , etc. ) . Recruitment also take place within New York Presbyterian Hospital . Subjects complete history physical examination office ; participant complete validate questionnaire informed consent , well urinalysis . Eligible participant enrol study randomize receive either dried cranberry placebo . The primary endpoint mean change number void per day measure use three-day voiding diary baseline end-of-treatment . Patients complete void diary 3 consecutive day prior clinic visit . Secondary endpoint include comparison patient 's baseline OAB symptom bother quality life , sexual function measure 4 validated questionnaire : OABQ-SF , PPBC , SQOL-F , PFDI-20 . The subject give device measure urinary volume throughout study . The study duration 6 month . Follow-up visit conduct 12 24 week . Adverse reaction complication obtain record Clavien-Dindo Grading System . The investigator seek determine dry cranberry powder change microbiome woman Overactive Bladder symptom versus placebo . At visit two ( baseline ) visit four ( end study visit ) stool urine sample collect 40 study participant 76 participant enrol study . The stool urine sample collect microbiome specimen analyze Genomics Core Epigenomics Core Weill Cornell Medical College . Participants study provide urine sample . The urine sample collect sterile container . Participants study provide one urine sample visit 2 ( Baseline visit ) another sample visit 4 ( end study ) . These sample subsequently analyze presence/ absence microbiota . This include DNA extraction , library preparation , shotgun next-generation sequencing , follow-up metagenomics microbiome analysis use bioinformatics alignment tool , order identify microbial specie strain . Participants study provide one stool sample visit 2 study another visit 4 study . Stool sample self-collected use clean catch receptacle ( e.g . plastic invert hat ) plastic scoop transfer feces 6 sterile tube .</detailed_description>
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<criteria>Ambulatory female subject ≥ 18 year age able use toilet without difficulty OAB symptom ≥ 6 month Frequency micturition ≥ 8 time per 24 hr ≥ 3 episode urgency ( grade 3 4 ) without incontinence 3day micturition diary period baseline Subjects willing maintain normal eating/drinking habit exercise habit avoid change body weight duration study Speak English able understand nature study Able give sign write informed consent Signed informed consent form Significant bladder outflow obstruction Urinary Incontinence ( define great 3 incontinence episode month prior screen ) Catheterization ( indwell catheter ) Diabetic neuropathy unstable diabetes mellitus Urinary tract infection ( UTI ) screen recurrent UTI define ≥ 3 UTIs previous 12 month Urethral diverticulum Neurogenic bladder Chronic urologic inflammatory condition ( Interstitial cystitis , urethral syndrome , painful bladder syndrome ) Bladder stone History carcinoma urinary tract Lower urinary tract surgery last 6 month Abnormal baseline urinalysis Previous pelvic radiation therapy previous , current malignant disease pelvic organ receive intravesical injection electrostimluation past 12 month Planning undergo urologic procedure mucosal bleed anticipate Drug Nondrug treatment OAB ( previous 56 day ) , Concomitant medication affect detrusor activity Cerebrovascular diseases Neurological impairment psychiatric disorder prevent appropriate understanding consent ability comply site personnel instruction History drug alcohol abuse within last 12 month . Has participate study involve administration investigational agent within past 30 day , within six halflives prior investigational agent , whichever longer . Subjects Warfarin Females childbearing potential pregnant planning become pregnant course study breastfeed Subjects history kidney stone Treatable condition could cause urinary incontinence urgency Planning undergo urologic procedure mucosal bleed anticipate Previous allergic condition cranberry product Gastrointestinal obstruction retention fecal impaction Failure complete baseline 3day diary Subjects unable swallow capsule intervention Subjects gross hematuria Judged investigator unsuitable enrollment study reason Allergy sensitivity aspirin Aspirin dose &gt; 81 mg Subjects take prescription antiplatelet agent ( e.g . clopidogrel , ticlopidine , prasugrel , ticagrelor ) Subject moderate severe hepatic impairment ( ChildPugh class B C ) Subject severe renal impairment define eGFR &lt; 30 mL/min/1.73 m2 )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>